Gene-Edited T Cell Therapy Players Battle Safety Doubts
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
22/10/2021 - 5 minutes
What’s new
Arming Biological Nanobots to Deliver Drugs Inside Our Bodies
Nanobots are tiny biological machines that can deliver drugs to the target destination to make…
20/10/2021 - 7 minutes
Biotech VCs Face Funding Bulge Amid Struggling Stock Markets
Despite volatile biotech stocks limiting options for exit, Sofinnova Partners’ latest €472M fund highlights ballooning…
19/10/2021 - 5 minutes
Sponsored
by Merck
Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO
Biotech firms partner with contract development and manufacturing organizations (CDMOs) to leverage their expertise in…
19/10/2021 - 8 minutes
Could We See a New Dawn for Hair Loss Treatments?
There hasn’t been a new hair loss drug approved in twenty years. But a number…
18/10/2021 - 7 minutes
Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO
Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry,…
15/10/2021 - 5 minutes
Thinking About Risk Early on Is Key for Cell Therapy Success
For cell therapy to become mainstream, important issues such as management of risk and quality…
13/10/2021 - 7 minutes
Sponsored
by CDD Vault
How Managing Data Effectively Helps Fight Antimicrobial Resistance
The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial,…
12/10/2021 - 9 minutes
The Top European Biotech Investment Rounds in September
Initial public offerings by European biotech companies were hot in September, and companies developing technologies…
12/10/2021 - 4 minutes
A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
11/10/2021 - 10 minutes
Longevity Foundation to Fund Geroscience Research with €860M
The newly-created Longevity Science Foundation aims to extend the human lifespan to more than 120…
11/10/2021 - 5 minutes
Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery
Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts…
07/10/2021 - 5 minutes
